Study to Evaluate Safety and Immunogenicity of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children
Clinical trial NCT01003418 · TERMINATED
Trial details
- NCT number
- NCT01003418
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-17
- Primary completion
- 2010-11-25
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.